Drug Trial Radar · NCT00479726
Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
Last checked: Nov 20, 2026Latest source record: May 28, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
8,000
Actual
Start
Aug 2004
Primary completion
Not stated
Study completion Jan 2005
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- May 28, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting
Conditions
- Major Depressive Disorder
Interventions
duloxetine hydrochlorideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Global Impression of Severity
- Somatic Symptom Inventory
- Depressive Symptomatology-Self Report
Locations
1 site in 1 country. Site status is shown where the registry gives one.
For additional information regarding investigative sites for this trial,contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Indianapolis, Indiana
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.